2020 ASCO Virtual Direct™ Highlights

 

Breast
06:58

2020 ASCO Virtual Direct™ Highlights

Early Stage HER2+ BC: How Effective Is Adjuvant Neratinib?

FEATURING Hope Rugo
  • 684 views
  • January 19, 2021
  • 2
11:36

2020 ASCO Virtual Direct™ Highlights

Treating Early Stage HER2+ BC: Which Patients Need New HER2-Targeted Agents?

FEATURING Hope Rugo
  • 349 views
  • January 19, 2021
  • 2
14:12

Total Health

HER2+ Targeted Agents for MBC: How to Best Sequence in Clinical Practice and Individualize Treatment Strategy?

FEATURING Hope Rugo
  • 884 views
  • January 12, 2021
  • 5
09:40

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on BC Adjuvant Therapy: What Is The Value of Early Local Therapy on Intact Primary Tumors in Patients With MBC?

FEATURING Mark Pegram
  • 267 views
  • August 18, 2020
06:25

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on BC Adjuvant Therapy: Has Anthracycline Finally Been Derailed in HER2+ EBC?

FEATURING Mark Pegram
  • 722 views
  • August 18, 2020
08:49

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on BC Adjuvant Therapy: Is There a Role for Adjuvant Endocrine Therapy Combined With CDK4/6i in Early Stage Disease?

FEATURING Mark Pegram
  • 234 views
  • August 18, 2020
  • 1
09:16

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ BC Adjuvant Therapy: Can We Substitute TDM-1 + Pertuzumab for Paclitaxel + Pertuzumab + Trastuzumab Following 4 Cycles of AC?

FEATURING Mark Pegram
  • 119 views
  • August 18, 2020
  • 1
10:52

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Adjuvant Therapy in TNBC: Is the Addition of Pembrolizumab Practice Changing? Does Maintenance Therapy w/ Metronomic Capecitabine Improve DFS?

FEATURING Mark Pegram
  • 1,775 views
  • August 13, 2020
  • 10
15:24

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HR+ MBC: Is There an Optimal Hormone Partner in the 1L Setting With CDK4/6i? Is There a Benefit to Alpelisib/Fulvestrant After Progression on CDKi?

FEATURING Hope Rugo
  • 235 views
  • August 19, 2020
  • 1
09:48

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on IO in mTNBC: Does TMB Impact the Clinical Outcome With Pembrolizumab vs. Chemotherapy?

FEATURING Hope Rugo
  • 771 views
  • August 26, 2020
  • 5
10:52

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ MBC: Does Tucatinib Combined With Trastuzumab and Capecitabine Have the Potential to Become a New SoC?

FEATURING Hope Rugo
  • 489 views
  • August 13, 2020
  • 3
16:42

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Optimized Therapy in Early Stage HER2+ BC: Can We Use Less Chemo in Certain Settings? What Is the Optimal Duration of Trastuzumab?

FEATURING Hope Rugo
  • 188 views
  • August 13, 2020